MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

494802

Report Date :

03.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

MSN LABORATORIES PRIVATE LIMITED (w.e.f. 27.02.2013)

 

 

Formerly Known As :

MSN LABORATORIES LIMITED

 

 

Registered Office :

MSN House, Plot No. C-24, Sanath Nagar Industrial Estate, Sanath Nagar, Hyderabad – 500018, Telangana

Tel. No.:

91-40-30438600

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

27.08.2003

 

 

Com. Reg. No.:

36-041583

 

 

Capital Investment / Paid-up Capital :

INR 52.000 Million

 

 

CIN No.:

[Company Identification No.]

U24239TG2003PTC041583

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

GSTN :

[Goods & Service Tax Registration No.]

36AADCM6283F1ZD

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AADCM6283F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Different types of Bulk Drugs, Formulations and its Intermediates. (Registered Activity)

 

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A++

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

 

Maximum Credit Limit :

USD 30000000

 

 

Status :

Excellent

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

MSN Laboratories Private Limited is a manufacturer of different types of bulk drugs, formulations and its intermediates. The company was started in the year 2003 and is based in Hyderabad, Telangana. It is an established company having fine track record.

 

As per Registrar of Companies the date of balance sheet (i.e. financial filed) is shown as 31.03.2017 but the documents related to the financial for the year 2017 are not available from any sources.

 

As per available financials of 2016, the company has witnessed a healthy growth in its revenue and has achieved decent profit margin at 20.33% (approx.)

 

The company possesses robust financial risk profile marked by strong net worth base along with negligible debt recorded by the company.

 

The company also derives strength from its long standing track record of business operations.

 

Fundamentals of the company are strong and healthy.

 

Trade relations are reported as fair. Business is active. Payment terms are seems to be regular and as per commitments.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating: A

Rating Explanation

Adequate degree of safety and low credit risk.

Date

February, 2018

 

Rating Agency Name

CRISIL

Rating

Short term rating: A1

Rating Explanation

Very strong degree of safety and carry lowest credit risk.

Date

February, 2018

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 03.03.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED

 

Management Non-Cooperative (91-40-30438600)

 

 

LOCATIONS

 

Registered/ Corporate Office :

MSN House, Plot No. C 24, Sanath Nagar Industrial Estate, Sanath Nagar, Hyderabad – 500018, Telangana, India

Tel. No.:

91-40-30438600

Fax No.:

91-40-30438638 / 30438719/ 30438643

E-Mail :

drmsnreddy@msnlabs.com

vinodchawla@msnlabs.com

Website :

http://www.msnlabs.com

 

 

API FACILITIES

 

API Unit 1 :

Sy No 317 and 323, Rudraram (Village), Patancheru Mandal, District Medak - 502329, Andhra Pradesh, India

Tel. No.:

91-8455-220372/ 373/ 305600

Fax No.:

91-8455-220415

E-Mail :

api@msnlabs.com

 

 

API Unit 2 Oncology Division:

SY. No. 50, Kardanur (V), Patancheru (M), District Medak – 502300, Telangana, India

Tel. No.:

91-8458-331200 

 

 

API Unit 3 :

Sy No- 14, Gaddapotharam (Village),  Jinnaram (Mandal), Sangareddy (District)- 502319,  Telangana, India

Tel. No.:

91-8458-304900

Fax No.:

91-8458-277085

 

 

FINISHED DOSAGE FACILITIES

 

Formulation Division Unit-1 :

Plot No. 42, Anrich Industrial Estate, Bollaram (V), District Medak - 502325, Telangana, India

Tel. No.:

91-8458-304950

Fax No.:

91-8458-279938 

E-Mail :

formulation@msnlabs.com

 

 

Formulation Division Unit-2:

Survey Nos. 1277 and 1319 to 1324, Nandigama (V), Kothur (M), District Mahabub Nagar - 509216, Andhra Pradesh, India

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Manne Satyanarayana Reddy

Designation :

Managing director

Address :

H. No. 8-3-167/D/16, Kalyan Nagar, Phase-1, Near A.G. Colony, Hyderabad – 500038, Telangana, India

Date of Birth/Age :

18.04.1957

Qualification :

M.Sc. Ph. D

Date of Appointment :

27.08.2003

PAN No.:

ADYPM2116L

DIN No.:

01657567

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U05005TG1995PTC021411

PRATHIMA EGGSEL PRIVATE LIMITED

30/09/2017

-

U55101TG1997PTC027938

PRATHIMA RESORTS AND RESTAURANTS PRIVATE LIMITED

30/09/2017

-

U24239TG2002PTC038674

MAITHRI LABORATORIES PRIVATE LIMITED

19/12/2003

-

U24239TG2005PTC047655

MSN LIFE SCIENCES PRIVATE LIMITED

22/04/2013

-

U24110TG2006PTC051858

MSN ORGANICS PRIVATE LIMITED

25/08/2012

-

U40105TG2007PTC056820

SPARK VIDYUTH PRIVATE LIMITED

01/11/2014

-

U73100TG2008PTC058892

MSN RESEARCH & DEVELOPMENT PRIVATE LIMITED

29/04/2008

-

U80300TG2010PTC068094

MSN INSTITUTE OF MEDICAL SCIENCES PRIVATE LIMITED

23/04/2010

-

U40107TG2013PTC086010

MSN ENERGY INDIA PRIVATE LIMITED

01/03/2013

-

U24100TG2013PTC085821

MAITHRI DRUGS PRIVATE LIMITED

18/02/2013

-

U24239TG2004PTC044631

MSN PHARMACHEM PRIVATE LIMITED

17/11/2004

-

U45209TG2013PTC086132

MSN INFRATECH PRIVATE LIMITED

06/03/2013

-

U01100TG2017PTC115434

MSS FARMS PRIVATE LIMITED

22/02/2017

-

U01100TG2017PTC116017

VAKULA AGROS PRIVATE LIMITED

20/03/2017

-

U01400TG2017PTC119446

ADRIJA FARMS PRIVATE LIMITED

11/09/2017

-

U01110TG2017PTC119447

MRINAL FARMS PRIVATE LIMITED

11/09/2017

-

U01820TG2017PTC119538

PRADYUMNA AGROS PRIVATE LIMITED

14/09/2017

-

U01100TG2017PTC119684

PRAYAGA GREEN MEADOWS PRIVATE LIMITED

22/09/2017

-

 

 

Name :

Mrs. Manne Laxmi Prasuna

Designation :

Director

Address :

H. No. 8-3-167/D/16, Kalyan Nagar, Phase-1, Near A.G. Colony, Hyderabad – 500038, Telangana, India

Date of Birth/Age :

06.08.1966

Date of Appointment :

27.08.2003

PAN No.:

AOJPM1556Q

DIN No.:

00954334

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24239TG2002PTC038674

MAITHRI LABORATORIES PRIVATE LIMITED

01/04/2011

-

U24239TG2005PTC047655

MSN LIFE SCIENCES PRIVATE LIMITED

22/04/2013

-

U24110TG2006PTC051858

MSN ORGANICS PRIVATE LIMITED

30/11/2006

-

U73100TG2008PTC058892

MSN RESEARCH & DEVELOPMENT PRIVATE LIMITED

29/04/2008

-

U24232TG2010PTC067538

SAAP BIOTECH PRIVATE LIMITED

12/03/2010

-

U80300TG2010PTC068094

MSN INSTITUTE OF MEDICAL SCIENCES PRIVATE LIMITED

23/04/2010

-

U01119TG2011PTC073554

ROSE GREENFIELDS PRIVATE LIMITED

28/03/2011

-

U01403TG2011PTC073521

ARM FARMS PRIVATE LIMITED

25/03/2011

-

U40107TG2013PTC086010

MSN ENERGY INDIA PRIVATE LIMITED

01/03/2013

-

U01403TG2014PTC094127

LAXMI SINDHUJA FARMS N ESTATES PRIVATE LIMITED

23/05/2014

-

U01403TG2014PTC094196

ACHYUTHA LAXMI FARMS N ESTATES PRIVATE LIMITED

27/05/2014

-

U01407TG2014PTC094189

MLP FARMS N ESTATES PRIVATE LIMITED

27/05/2014

-

U29222TG2014PTC096936

SV INDUSTRIAL INFRA PRIVATE LIMITED

25/03/2016

-

U24239TG2004PTC044631

MSN PHARMACHEM PRIVATE LIMITED

17/11/2004

-

U45209TG2013PTC086132

MSN INFRATECH PRIVATE LIMITED

06/03/2013

-

U01400TG2017PTC119446

ADRIJA FARMS PRIVATE LIMITED

11/09/2017

-

U01110TG2017PTC119448

VARENYA HORTICULTURE PRIVATE LIMITED

11/09/2017

-

U01114TG2017PTC119666

DAKSHAYANI HORTICULTURE PRIVATE LIMITED

21/09/2017

-

 

 

Name :

Mr. Bharat Reddy Chintapally

Designation :

Director

Address :

H. No. 8-3-167/D/16, Kalyan Nagar, Phase-1, Near A.G. Colony, Hyderabad – 500038, Telangana, India

Date of Birth/Age :

30.06.1969

Qualification :

MS., MBA

Date of Appointment :

01.02.2007

PAN No.:

AGQPC2221B

DIN No.:

01591473

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24110TG2006PTC051858

MSN ORGANICS PRIVATE LIMITED

29/09/2007

-

U73100TG2008PTC058892

MSN RESEARCH & DEVELOPMENT PRIVATE LIMITED

29/04/2008

-

 

 

KEY EXECUTIVES

 

Name :

Mr. Vinod Kumar Chawla

Designation :

Company Secretary

Address :

1-1, 365/A/SHSH/G-01, Street No - 06, Heritage Fresh Jawahar Nagar, Musheerabaad (Delivery), Musheeraba, Hyderabad- 500020, Telangana, India

Date of Appointment :

25.07.2012

PAN No.:

AGPPC5797F

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders

 

No. of Shares

Manne Satyanarayana Reddy

 

2526800

Manne Laxmi Prasuna

 

427800

Manne Venkat Ram Reddy

 

120000

Thatikonda Seetha

 

1000

Thatikonda Srinivas

 

1000

Chintapally Anjani

 

1000

Chintapally Janardhan Reddy

 

132000

Manne Venkat Pratap Reddy

 

124000

Manne Jeevan Reddy

 

120000

Manne Srinivasa Reddy

 

120000

Manne Nirmala Devi

 

66000

Manne Geetha

 

55000

Thatikonda Sreedhar Reddy

 

1000

Srinivasan Tirumalarajan

 

72000

Sajja Eswaraiah

 

72000

Challa N.V. Ravi Kumar

 

72000

Muppa Kishore Kumar

 

72000

Chintapally Bharat Reddy

 

700000

Manne Madhavi

 

1200

Thatikonda Varalakshmamma

 

1000

Chintapally Vasudha

 

1000

Thatikonda Raja Reddy

 

1000

Manne Swathi

 

1200

Chakilam Nagaraju

 

456000

Manne Shrawya Reddy

 

55000

 

 

 

Total

 

5200000

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 30.09.2017

 

Category

Percentage

Promoters- Individual/Hindu Undivided Family- Indian

65.59

Public/Other than promoters- Individual/Hindu Undivided Family- Indian

34.41

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Different types of Bulk Drugs, Formulations and its Intermediates. (Registered Activity)

 

 

Products / Services :

Name and Description of main products / services

ITC Code of the Product/service

Rosuvastain Calcium

29420090

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

Bankers :

Banker Name :

Yes Bank Limited

Branch :

Ground Floor, Mayank Towers, Survey no. 31(old)31/2(new), Raj Bhavan Road, Somajiguda, Hyderabad - 500082, Telangana, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

  • Axis Bank Limited, 5-2-183/184,ASC Centre, III Floor, R.P Road, Hyderabad - 500003, Telangana, India
  • The Hongkong and Shanghai Banking Corporation Limited, 6-3-1107 & 1108, Raj Bhavan Road, Somaji Guda, Hyderabad - 500082, Telangana, India
  • Indusind Bank Limited, 2401 Gen Thimmayya Road, Contonment, Pune -411001, Maharashtra, India
  • ICICI Bank Limited, ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara - 390007, Gujarat, India

 

 

Facilities :

(INR In Million)

SECURED LOAN

As on

31.03.2016

As on

31.03.2015

LONG TERM BORROWING

 

 

Rupee term loans from banks

708.333

400.000

Loans taken for fixed assets

19.044

10.653

SHORT TERM BORROWING

 

 

Working capital loans from banks

0.000

100.947

Loans repayable on demand from banks

1218.485

1046.752

Total

1945.862

1558.352

 

 

Auditors :

 

Name :

B.R.M Reddy and Company

Chartered Accountants

Address :

6-3-1186/A/6, 2nd Floor, Lane adj. to Hotel ITC Kakatiya, Begumpet, Hyderabad – 500016, Telangana, India

Income-tax PAN of auditor or auditor's firm :

AADFB7698A

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises which are

owned, or have significant influence of or are partners with Key management personnel and their relatives (AS ON 31.03.2016):

  • MSN Pharmachem Private Limited, India [U24239TG2004PTC044631]
  • MSN Organics Private Limited, India [U24110TG2006PTC051858]
  • Maithri Laboratories Private Limited, India [U24239TG2002PTC038674]
  • MSN Life Sciences Private Limited, India [U24239TG2005PTC047655]
  • Maithri Drugs Private Limited, India [U24100TG2013PTC085821]
  • MSN Research and Development Private Limited, India [U73100TG2008PTC058892]

 

 

Subsidiary company (AS ON 31.03.2016):

  • M S N Pharmeceuticals Inc, USA

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

INR 10/- each

INR 100.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5200000

Equity Shares

INR 10/- each

INR 52.000 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

 

ABRIDGED BALANCE SHEET (STANDALONE)

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

52.000

52.000

52.000

(b) Reserves and Surplus

10596.923

8075.673

5771.222

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

10648.923

8127.673

5823.222

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

727.377

410.653

59.843

(b) Deferred tax liabilities (Net)

528.594

359.570

243.515

(c) Other long-term liabilities

7.700

7.500

7.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

1263.671

777.723

310.358

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

1218.485

1147.699

621.386

(b) Trade payables

1340.006

2756.886

2175.266

(c) Other current liabilities

344.326

276.557

178.543

(d) Short-term provisions

111.857

0.819

31.314

Total Current Liabilities (4)

3014.674

4181.961

3006.509

 

 

 

 

TOTAL

14927.268

13087.357

9140.089

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

4554.405

3789.840

1826.995

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Tangible assets capital work-in-progress

545.289

798.060

1497.141

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

30.589

30.589

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

961.841

831.519

707.440

(e) Other Non-current assets

0.200

0.842

5.695

Total Non-Current Assets

6092.324

5450.850

4037.271

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

2381.839

1897.781

1171.147

(c) Trade receivables

5407.256

4822.640

3332.145

(d) Cash and bank balances

186.075

167.637

157.559

(e) Short-term loans and advances

859.774

748.449

441.967

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

8834.944

7636.507

5102.818

 

 

 

 

TOTAL

14927.268

13087.357

9140.089

 

 

PROFIT & LOSS ACCOUNT (STANDALONE)

 

 

 

PARTICULARS

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

Income

12710.543

9171.823

8506.341

 

Other Income

188.412

98.000

184.419

 

TOTAL

12898.955

9269.823

8690.760

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

4856.806

3087.936

3317.273

 

Purchases of Stock-in-Trade

56.255

109.805

26.347

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(269.676)

(410.052)

(28.471)

 

Employee benefit expense

1454.880

1094.626

536.916

 

Other expenses

2437.238

1866.132

1640.507

 

TOTAL

8535.503

5748.447

5492.572

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

4363.452

3521.376

3198.188

 

 

 

 

 

Less

FINANCIAL EXPENSES

134.433

106.225

99.639

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

4229.019

3415.151

3098.549

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

297.109

217.011

92.429

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

3931.910

3198.140

3006.120

 

 

 

 

 

Less

TAX

1348.073

862.366

892.401

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

2583.837

2335.774

2113.719

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE

BROUGHT FORWARD

7304.443

5233.570

3361.642

 

 

 

 

 

 

APPROPRIATIONS

320.970

264.900

320.970

 

 

 

 

 

 

Balance Carried to the B/S

9567.310

7304.444

5233.570

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

7039.903

5179.347

5484.853

 

TOTAL EARNINGS

7039.903

5179.347

5484.853

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

1435.058

1018.500

877.239

 

Components and spare parts

9.430

1.686

1.684

 

Capital Goods

236.137

455.286

239.810

 

TOTAL IMPORTS

1680.625

1475.472

1118.733

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

496.89

449.00

406.00

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

216.579

164.910

130.343

 

 

 

 

Cash generated from operations

NA

NA

NA

 

 

 

 

Net cash flows from (used in) operations

1749.363

1645.810

2689.941

 

 

 

 

Net cash flows from (used in) operating activities

551.381

885.534

1833.041

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

(Sundry Debtors / Income * 365 Days)

155.28

191.92

142.98

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

2.35

1.90

2.55

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

99.55

314.68

237.46

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.83

1.86

2.73

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.86

0.77

0.96

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

155.28

191.92

142.98

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

2.35

1.90

2.55

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

99.55

314.68

237.46

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

1.83

1.86

2.73

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

0.86

0.77

0.96

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin

((PAT / Sales) * 100)

%

20.33

25.47

24.85

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

17.31

17.85

23.13

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

24.26

28.74

36.30

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

2.93

1.83

1.70

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

2.14

1.37

1.31

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.71

0.62

0.64

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

41.59

33.14

15.61

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

2.93

1.83

1.70

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

52.000

52.000

52.000

Reserves & Surplus

5771.222

8075.673

10596.923

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

5823.222

8127.673

10648.923

 

 

 

 

Long-term borrowings

59.843

410.653

727.377

Short term borrowings

621.386

1147.699

1218.485

Current maturities of long-term debts

130.343

164.910

216.579

Total borrowings

811.572

1723.262

2162.441

Debt/Equity ratio

0.139

0.212

0.203

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

8506.341

9171.823

12710.543

 

 

7.823

38.583

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

8506.341

9171.823

12710.543

Profit/ (Loss)

2113.719

2335.774

2583.837

 

24.85 %

25.47 %

20.33 %

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

 

SOURCES OF FUNDS

 

 

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

52.000

52.000

(b) Reserves and Surplus

 

10713.093

8135.168

(c) Money received against share warrants

 

0.000

0.000

(d) Minority interest

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

10765.093

8187.168

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

727.376

410.653

(b) Deferred tax liabilities (Net)

 

528.594

359.570

(c) Other long-term liabilities

 

6.700

6.500

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

1262.670

776.723

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

 

1218.485

1147.699

(b) Trade payables

 

1309.143

2706.060

(c) Other current liabilities

 

345.326

277.556

(d) Short-term provisions

 

111.857

0.819

Total Current Liabilities (4)

 

2984.811

4132.134

 

 

 

 

TOTAL

 

15012.574

13096.025

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

4557.093

3792.744

(ii) Intangible Assets

 

522.479

523.620

(iii) Tangible assets capital work-in-progress

 

545.286

798.060

(iv) Intangible assets under development

 

0.000

3.143

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d) Long-term loans and advances

 

500.655

282.747

(e) Other Non-current assets

 

0.200

0.842

Total Non-Current Assets

 

6125.713

5401.156

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

2381.840

1897.781

(c) Trade receivables

 

5432.346

4855.588

(d) Cash and bank balances

 

212.901

193.050

(e) Short-term loans and advances

 

859.774

748.450

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

8886.861

7694.869

 

 

 

 

TOTAL

 

15012.574

13096.025

 

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

 

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

 

12710.542

9171.824

 

Other Income

 

212.696

150.980

 

TOTAL

 

12923.238

9322.804

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

4856.806

3087.936

 

Purchases of Stock-in-Trade

 

56.255

109.805

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(269.676)

(410.052)

 

Employee benefit expense

 

1486.957

1126.237

 

Other expenses

 

2380.294

1804.872

 

TOTAL

 

8510.636

5718.798

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

4412.602

3604.006

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

134.433

106.225

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

4278.169

3497.781

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

333.179

226.597

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

3944.990

3271.184

 

 

 

 

 

Less

TAX

 

1348.228

862.540

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

2596.762

2408.644

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

499.38

463.20

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

 

FINANCIAL PERFORMANCE (AS ON 31.03.2016)

 

For the financial year ended March 31, 2016, gross sales was 13032.573 Million as compared to INR 9388.325 Million in the corresponding period of the previous year. The EBITDA for the financial year 2015-16 stood at 4363.452 Million compared to EBITDA 3521.377 Million during the corresponding period of previous year. The Net profit was INR 2583.837 Million for FY 2014-15 as compared to INR 2335.774 Million in the corresponding period of the previous year.

 

BUSINESS REVIEW (AS ON 31.03.2016)

 

The Company presently has two world class bulk actives and chemicals manufacturing facility situated at Rudraram, Medak District, and Kardanur, Medak District near Hyderabad and two finished dosages manufacturing facility at Anrich Industrial Estate, Bollaram, Medak District and Nandigama, Mahaboobnagar Dist., Near Hyderabad.

 

BULK ACTIVES (AS ON 31.03.2016)

 

The Company produces around 104 bulk actives in addition to the other chemicals and intermediates in its bulk actives facility. Of this the major products are Rosuvastatin, Oseltamivir, Pregabalin, Clopidogrel, Voricanazole, Ezetimibe, Atoravastatin, Mantelukast, Eplerenone and Tofacitinib and which together contribute over 56% of the product revenues.

 

The Company continues its efforts to build a stronger customer base, both in domestic as well as export markets. The share of export revenues contributes 61% of the total revenues. The Company expects that the share of export revenues would increase in the years to come. This being propelled mainly through conscious efforts to increase its regulatory filings, customer partnerships, etc.

 

The Company has filed, in the Indian Patent Office, 60 intellectual property rights applications. Similarly, 10 applications have been filed under Patents Cooperation Treaty (PCT) during FY 2015-16

 

The company has filed 24 DMFs including CEPS in US, Eurpoe, Canada and Taiwan etc during the FY 2015-16.

 

FINISHED DOSAGES BUSINESS (AS ON 31.03.2016)

 

The Company produces over 140 products in its finished dosage basket. The company has ventured into chronic therapy-Lifestyle diseases which is the biggest threat to the country. This segment, covering invasive and degenerative diseases, is one of the fastest growing segments world over and India in particular. The successful presence of their finished dosages business enables the Company in moving up the value chain in the pharmaceutical vertical.

 

During the year, the Company has successfully expanded its market reach by establishing a strong presence in the market. As Domestic Formulations Company they have started making inroads in the market and are able to make a mark in the Indian Market.

 

The Company is making necessary efforts in registering its products in various countries in the semi-regulated markets of the world. Distribution partners have been identified in many countries in Asia-Pacific, Latin America, Africa and some parts of CIS.

 

 

 

INDEX OF CHARGE:

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

G75922641

100152113

YES BANK LIMITED

29/12/2017

-

-

3500000000.0

GROUND FLOOR, MAYANK TOWERS, SURVEY NO. 31(OLD)31/2(NEW), RAJ BHAVAN ROAD, SOMAJIGUDAHYDERABADTG500082IN

2

G15684491

100054993

AXIS BANK LIMITED

21/09/2016

-

-

2317500.0

5-2-183/184,ASC CENTRE, III FLOORR.P ROADHYDERABADTG500003IN

3

G52427598

100042434

THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED

13/07/2016

11/08/2017

-

750000000.0

6-3-1107 & 1108, RAJ BHAVAN ROADSOMAJIGUDAHYDERABADTG500082IN

4

G74661505

10565506

INDUSIND BANK LTD.

27/03/2015

29/12/2017

-

2390000000.0

2401 GEN THIMMAYYA ROADCONTONMENTPUNEMA411001IN

5

C40286726

10530233

AXIS BANK LIMITED

30/10/2014

24/12/2014

-

1700000.0

RETAIL ASSET CENTRE, 5-2-183/184,3RD FLOOR,R.P ROADSECUNDERABADTG500003IN

6

B63884381

10372144

ICICI BANK LIMITED

13/08/2012

15/11/2012

-

200000000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

7

G51428118

10333818

ICICI BANK LIMITED

24/01/2012

16/08/2017

-

1200000000.0

ICICI BANK TOWER, NEAR CHAKLI CIRCLE,OLD PADRA ROADVADODARAGU390007IN

8

A71194419

10016973

AXIS BANK LIMITED

19/08/2006

24/09/2009

-

65000000.0

CREDIT MANAGEMENT CENTRE, 5-2-183/184, 8751(OLD)IIIRD FLOOR, R P ROADSECUNDERABADAP500003IN

9

G52227337

90126902

AXIS BANK LIMITED

25/08/2004

16/08/2017

-

950000000.0

CORPORATE BANKING BRANCH, 1ST FLOOR,PULLAREDDY BUILDINGS, GREENLANDS, BEGUMPETHYDERABADTG500016IN

10

B78113958

10068165

3I INFOTECH TRUSTEESHIP SERVICES LIMITED

27/09/2007

20/09/2011

22/06/2013

200000000.0

3RD TO 6TH FLOOR, INTERNATIONAL INFOTECH PARK,TOWER NO.5, VASHI RAILWAY STATION COMPLEX, VASHINAVI MUMBAIMH400703IN

 

 

FIXED ASSETS:

 

Tangible assets

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Office equipment
  • Computer equipments

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.23

UK Pound

1

INR 89.71

Euro

1

INR 79.50

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

KVT

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.